The uptake of the oxidation products of two oxovanadium(IV) compounds, [N,N 0 -ethylenebis(pyridoxylaminato)]oxovanadium(IV), V IV O(Rpyr 2 en), and bis-[3-hydroxy-1,2-dimethyl-4-pyridinonato]oxovanadium(IV), V IV O(dmpp) 2 , by human erythrocytes was studied using 51 V and 1 H NMR and EPR spectroscopy. V IV O(Rpyr 2 en) in aerobic aqueous solution is oxidized to its V V counterpart and the neutral form slowly enters the cells by passive diffusion. In aerobic conditions, V IV O(dmpp) 2 originates V V complexes of 1:1 and 1:2 stoichiometry. The neutral 1:1 species is taken up by erythrocytes through passive diffusion in a temperature-dependent process; its depletion from the extracellular medium promotes the dissociation of the negatively charged 1:2 species, and the protonation of the negatively charged 1:1 species. The identity of these complexes is not maintained inside the cells, and the intracellular EPR spectra suggest N 2 O 2 or NO 3 intracellular coordinating environments. The oxidative stress induced by the oxovanadium compounds in erythrocytes was not significant at 1 mM concentration, but was increased by both vanadate and oxidized V IV O(dmpp) 2 at 5 mM. Only 1 mM oxidized V IV O(dmpp) 2 significantly stimulated erythrocytes glucose intake (0.75 ± 0.13 against 0.37 ± 0.17 mM/h found for the control, p < 0.05).
Introduction
Many vanadium salts and their complexes have shown insulin mimetic pharmacological properties, including stimulation of glucose transport into cells and its oxidation via glycolysis, glycogen synthesis and lipogenesis, as well as inhibition of gluconeogenesis and glycogenolysis [1] [2] [3] [4] . These anti-diabetic properties of vanadium compounds, which have been demonstrated by in vitro [5] [6] [7] [8] [9] [10] , in vivo [11, 12] and clinical studies [2, 13, 14] , have attracted much interest as potential therapeutic agents for Diabetes mellitus [11, [15] [16] [17] [18] . They can be administered orally and have been shown to promote glucose uptake in animal models of type 1 and type 2 diabetes [13, 19] . However, toxicity, although lower in vanadium complexes than for their salts, is still a major drawback, in particular for V IV compounds [13, 14, 18] .
Current research is underway to design new and more effective insulin mimetic vanadium compounds with lower toxicity. Key goals are to identify the active vanadium species and to understand their mechanism of action at the cellular and molecular levels. Vanadate and several V V compounds inhibit the activity of several enzymes [2, 20] in particular protein tyrosine phosphatases (PTPases) [9, 10, [21] [22] [23] [24] , increasing the phosphotyrosil content of key proteins of the insulin signaling cascade [6] . Adequate ligand design can efficiently increase the stability of the vanadium complex in the stomach and its absorption through the gastrointestinal (GI) tract, thereby reducing the effective pharmacological dose [25] . Studies with a variety of V V and V IV compounds with OO, ON, OS, NS and ONS ligand donor sets have shown the insulin mimetic activity of some of them as well as their low toxicity [26] [27] [28] [29] [30] [31] . The bioavailability of vanadium complexes can also be improved by increasing their GI absorption through their delivery in an intact form using, e.g., enteric-coating capsulation [32] [33] [34] .
In body fluids, vanadium is present in the +5 oxidation state as monovanadate ðH 2 VO À 4 Þ, which is isostructural with phosphate [35] , and can be transported into the cells through the anion channel of plasma membranes [36, 37] . Under the reducing conditions of the intracellular environment, where glutathione and reductase enzymes are present, monovanadate is non-enzymatically reduced to vanadyl (V IV O 2+ ), probably by cytoplasmatic glutathione [38] [39] [40] . V IV O 2+ also forms relatively stable adducts with proteins such as hemoglobin [37, 39, 40] . Glutathione was initially proposed as an efficient V IV O 2+ intracellular binder [41, 42] , but this activity was found to be low in biological media [43, 44] . The intracellular ligand environment of V IV species has been investigated by EPR and electron spin echo envelope modulation (ESEEM) spectroscopy through in vitro [45, 46] and in vivo [47] [48] [49] studies.
In this paper, we report a study of the uptake, intracellular reduction and binding of the aerobic oxidation products of two oxovanadium(IV) compounds in human erythrocytes, using 51 V and 1 H NMR and EPR spectroscopy. These compounds are the complexes [N,N 0 -ethylenebis(pyridoxylaminato)]oxovanadium(IV), V IV O(Rpyr 2 en) and bis-[3-hydroxy-1,2-dimethyl-4-pyridinonato]oxovanadium(IV), V IV O(dmpp) 2 (see Fig. 1 ), which have previously been synthesized and their structures, as well as those of the corresponding V V analogues, were characterized in the solid state and in solution [50] [51] [52] [53] [54] . They have also been shown by in vitro studies to be promising insulin mimetic candidates [18, 54] .
Experimental

General materials
All reagents and solvents were of the commercially available highest grade and used without further purification. NaCl, NaH 2 PO 4 
Blood processing
Blood was obtained following informed consent from healthy adult volunteers and was drawn by venipuncture into tubes containing Ôacid citric dextroseÕ as anticoagulant. Blood samples were immediately centrifuged for 10 min at 3000 rpm (1300g in a Heraeus Sepatech Labofuge Ae) and the plasma and buffy coat were removed and discarded. The erythrocytes were then resuspended in an equal volume of the adequate buffer, centrifuged as before and suspended again in fresh buffer. This process was repeated twice.
Preparation of erythrocyte lysates
After carrying out all the experiments, the erythrocyte suspensions were centrifuged to separate the erythrocytes from the supernatant and the supernatant discarded. The erythrocytes were washed twice with the PBS buffer, which was removed by centrifugation, frozen without the supernatant and kept at À20°C. When the samples were defrosted, lysis occurred immediately. To obtain homogenous erythrocyte lysates for EPR analysis, three freeze thaw cycles were carried out.
Uptake of vanadium compounds
The isolated erythrocytes were resuspended at a hematocrit of 45-50% in PBS containing 11 mM glucose with or without (control) 1 mM DIDS and were incubated at 25 or 37°C. Ten minutes later, solutions of 10 mM vanadate or 10 mM V IV O-compounds oxidation products were added to the cell suspensions to obtain a final concentration of 1 mM in the extracellular medium. Aliquots were taken at different time points and centrifuged for 10 min at 3000 rpm to separate the supernatant from erythrocytes. The extracellular medium of each aliquot was analyzed by 51 V NMR and the erythrocyte lysates were studied by EPR. In the experiments involving V IV O(dmpp) 2 , 100 ll of the supernatant of each sample were lyophilized and resuspended in 600 ll D 2 O for further 1 H NMR analysis. During all experiments, the pH was periodically measured to check if it deviated substantially from the 7.4 starting value.
2.5.
51 V NMR spectroscopy 51 V NMR spectra of the extracellular medium of the erythrocyte suspensions were obtained on a Varian Unity 500 Spectrometer equipped with a 5-mm broadband ''switchable'' probe with z-gradient (Varian, Palo Alto, CA, USA) operating at 131.399 MHz and at 25.0 ± 0.5°C. A single-pulse sequence with standard acquisition parameters for 51 V was used. The spectral parameters were as follows: sweep width 18727.6 Hz, pulse angle 45°(pulse width 25 ls), acquisition time 0.501 s, number of points 18k, relaxation delay 0.200 s, line broadening 50 Hz, zero filled to 30k. A sodium orthovanadate solution of known concentration (0.5 or 1.0 mM), pH 12 in a capillary (length: 75.00 ± 1.00 mm, inner circle diameter: 1.15 ± 0.05 mm, outer circle diameter: 1.55 ± 0.05 mm) inside the NMR tube was used as an external reference for quantitative analysis. The signals were integrated using the NUTS PC-based NMR spectral analysis program (Acorn NMR Inc., Fremont CA, USA).
1 H NMR spectroscopy
1 H NMR spectra of the lyophilized extracellular medium of erythrocyte samples were obtained on the same instrument operating at 499.824 MHz and at 25.0 ± 0.5°C. A single pulse sequence with standard acquisition parameters for 1 H with pre-saturation to suppress the water signal was used. Spectral parameters were as follows: sweep width 8000 Hz, pulse angle 51°(pulse width 11 ls), acquisition time 3.004 s, number of points 24k, relaxation delay 1.5 s, no line broadening, zero filled to 48k. The integrals of the signals were also determined using the NUTS PC-based NMR spectral analysis program.
EPR spectroscopy
EPR spectra were recorded at 77 K on a Bruker ESP 300E Spectrometer coupled to a Bruker ER 041 XK Xband frequency meter (9.45 GHz). The samples (erythrocyte lysates, aqueous solutions of V IV O complexes and VOSO 4 ) were previously frozen in liquid nitrogen. The settings used for all experiments were: microwave power: 2 mW; modulation amplitude: 3.6 G; time constant: 2.56 ms; conversion time 40.96 ms; sweep field: 3400 ± 1000 G. Spectral intensities were measured at the m I = À1/2^line. Spectra were simulated with a dedicated computer program [55] . In some cases (spectra with more than two species), hyperfine coupling constants and g-values were estimated using an iterative procedure based on equations proposed in the literature [56] and later corrected [57] . An empirical relationship [56] has been proposed to predict the A i from individual contributions of each donor group,
A similar additivity rule may be applied to g i . The A i and g i parameters show good sensitivity to the identity of the in-plane donor groups. This relationship is useful to estimate A i values within ±3 · 10 À4 cm À1 , and it can be used to establish the most probable binding mode for the V IV O moiety [56] [57] [58] [59] [60] [61] .
Oxidative stress effects
The erythrocytes were resuspended at $10% hematocrit in HEPES/saline buffer solution (for 60 min) at 37°C to wash out endogenous glucose and lactate. Then, the erythrocyte samples were centrifuged and resuspended at a hematocrit of 45-50% in HEPES/saline buffer containing 11 mM [2-
13 C]D-glucose. HEPES/saline buffer solutions of methylene blue, vanadate, V IV O(Rpyr 2 en) and V IV O(dmpp) 2 oxidation products were added to the erythrocyte suspension to test their oxidative toxicity. Their effect on the pentose phosphate pathway (PP) flux was compared with that of methylene blue, used as a standard stimulating agent of PP flux [62] . Erythrocyte samples were incubated at 37°C for 8 h and then centrifuged for 10 min at 3000 rpm. The supernatant of each sample (100 ll) was lyophilized and resuspended in 600 ll D 2 O for 1 H NMR analysis.
1 H NMR spectra of the lyophilized extracellular medium of all erythrocyte samples were recorded as mentioned above at 25.0 ± 0.5°C. The 13 C-1 H decoupling of the carbon 1 signal of lactate was achieved with low power singlefrequency irradiation continuously applied. Deconvolution and quantification of the 1 H signals of the methyl group of 13 C-labeled lactate was carried out with the curve-fitting routine supplied with the NUTS PC-based NMR spectral analysis program. The fraction of glucose-6-phosphate consumed by the pentose pathway relative to the total (glycolysis + pentose pathway) was calculated from the lactate 1 H methyl signal as already described [62] .
Glucose intake assay
To test the glucose intake by erythrocytes, the cell suspensions were prepared as described in the previous section using 11 mM of non-labeled glucose instead of [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]Dglucose. To evaluate the glucose consumption rates, HEPES/saline buffer solutions of methylene blue, vanadate or the two V IV O-compounds under study were added to the cell suspension to give final concentrations of 6.7 lM for methylene blue, and 1 mM for the other compounds. All erythrocyte samples were incubated at 37°C for 8 h and aliquots were taken every hour. These aliquots were then centrifuged for 10 min at 3000 rpm to separate the erythrocytes from the extracellular medium, which was boiled to precipitate the proteins. After centrifugation, the pellet was discarded and the glucose concentration in the supernatant was determined by a spectrophotometric biochemical assay from Boehringer Mannheim/R-Biopharm (Roche) based on the hexokinase method [63] .
Data analysis
Data are expressed as mean ± SEM and p < 0.05 was considered significant. Statistical significance was determined by using the StudentÕs t test and the number of replicates is indicated in each figure.
Results and discussion
Uptake of vanadium compounds by erythrocytes
The uptake by human erythrocytes of the V V oxidation products of the oxovanadium complexes V IV O(Rpyr 2 en) and V IV O(dmpp) 2 was investigated using NMR and EPR spectroscopy. These V V species present in the medium are reduced to V IV species inside the cells, as shown by their intracellular EPR signals (see below). The time evolution of the concentration of the V V species in the extracellular medium and of the V IV species inside the cells was followed by 51 V NMR and EPR spectroscopy, respectively. Human erythrocytes were chosen as our initial cell model for several reasons: (a) they are among the first cell systems to be affected by the vanadium compounds after they are absorbed in the GI tract; (b) have a simple morphology and physiology, together with well-known membrane transport systems; (c) have a well-defined metabolic mechanism for the maintenance of reduced glutathione levels during oxidative stress. Thus, erythrocytes allow both the study of cell uptake of vanadium compounds and their effects on intracellular metabolism and redox state.
NMR studies
Figs. 2A, 3 and 4A show the time dependence of the 51 V NMR spectra obtained from the extracellular medium of erythrocyte suspensions incubated with vanadate (25°C, 1 mM), oxidized V IV O(Rpyr 2 en) (37°C, 1 mM) and oxidized V IV O(dmpp) 2 (25 and 37°C, 1 mM), respectively. At the physiological conditions used, the 51 V NMR spectra of the medium with added vanadate contain three peaks at À562, À574 and À579 ppm, corresponding to mono-(V 1 ), di-(V 2 ), and tetravanadate (V 4 ), respectively, in slow exchange on the NMR timescale ( Fig. 2A) . These species are in a dynamic equilibrium with rate constants for the forward and reverse reactions of the order of milliseconds [64] . The 51 V NMR signal intensities of the three species decrease with time, faster for V 4 than for V 2 , being slower for V 1 , as shown by the signal integrals of the V i species (i = 1, 2, 4) ( Fig. 2B(a) ). It is likely that vanadate is transported across the erythrocyte membrane only as the monomer, as the properties of the monovanadate anion [37, 65] . Therefore, the fast decrease of the NMR signals corresponding to V 2 and V 4 indicates their decomposition into V 1 to reestablish the equilibrium as V 1 enters the erythrocytes.
The entry of V 1 in erythrocytes through the anion channel was confirmed by the absence of changes in the intensity of the 51 V NMR signals of the mono and polynuclear V V species with time in the extracellular medium for erythrocyte suspensions incubated with 1 mM vanadate and the specific anion channel blocker DIDS (Fig. 2B(b) ). These results are in agreement with data described in the literature using 48 V radioactive isotopes and EPR [36, 37, 66, 67] .
A semilogarithmic plot of the time decay of the total integral of the three 51 V NMR signals (which is a measure of the extracellular V V , as intracellular V V is NMR invisible [37] ) shows a biphasic kinetics of vanadate uptake, with a fast initial phase (t 1/2 $ 6 min) when V 1 enters the erythrocytes, followed by a slower phase (t 1/2 $ 118 min) (data not shown). These results are similar to those previously reported, using 48 V radioisotopes and EPR, where it is suggested that the slower phase of vanadate transport might be due to the reduction of V V to V IV within the cells, with intracellular retention of V IV [36, 67] . The differences in t 1/2 values obtained in this work relative to those described in the literature are probably due to the different experimental conditions used, e.g. the composition of the media, temperature, hematocrit and concentration of vanadate in the extracellular medium [67] .
Dissolution of the V IV O(Rpyr 2 en) complex in the aqueous buffer solution used, under aerobic conditions and at physiological pH (pH 7.45), leads to complete oxidation to the corresponding V V complex, V V O 2 (HRpyr 2 en) after 12 h, as checked by EPR. This complex has two isomers with 1:1 stoichiometry, the a-cis (or cis-phenolate, C I ) and b-cis (or trans-phenolate, C II ) complexes [50] . The 51 V NMR spectra in Fig. 3 show no significant changes in the intensity of the two 51 V NMR signals present in the extracellular medium of the erythrocyte suspensions incubated with the oxidized V IV O(Rpyr 2 en), assigned to the a-cis and b-cis isomers of V V O 2 (HRpyr 2 en), indicating that no significant uptake of this bulky complex is observed using 51 V NMR. The uptake of the complex might occur by passive diffusion of the neutral [V V O 2 (HRpyr 2 en)], which is expected to decrease from 60% to 40% mole fraction, when the medium pH drops from 7.45 to 6.8 after the 8 h incubation period [50] .
The uptake of the V IV O(dmpp) 2 oxidation products by erythrocytes was also studied using 51 V NMR spectroscopy. In aqueous aerobic unbuffered solution at an initial pH 7.4, V IV O(dmpp) 2 is fully oxidized to two V V species with 1:1 and 1:2 stoichiometries, while the solution pH drops to 4.7 [53] . Fig. 4A shows the 51 V NMR spectra of the extracellular medium of human erythrocyte suspensions, previously incubated with 1 mM oxidized V IV O(dmpp) 2 , as a function of time at two different temperatures: 25°C (Fig. 4A(a) ) and 37°C (Fig. 4A(b) ). Two 51 V NMR signals are observed at À483 and À507 ppm, corresponding to the 1:2 and 1:1 complexes, respectively [53] . Despite the presence of buffer, the measured pH dropped to 6.8 along the experiment, as confirmed by the reported 51 V chemical shifts [53] . In these conditions, the 1:2 complex is present exclusively as the mononegative species [V The decrease of the 51 V NMR signal intensity of the two V V complexes present in the extracellular medium is considerably faster at 37°C, and is faster for the negatively charged 1:2 species at both temperatures and at all times, as shown in Fig. 4B(a) . At 37°C, the concentration of the 1:1 complex decreases to $23% of the initial value in 15 min, to $11% after 30 min, and then remains constant until 120 min. At 25°C, it does not change significantly during the first 30 min and then decreases to approximately 50% (after 120 min). The 1:
À (L = dmpp) rapidly disappears from the extracellular medium at 37°C, whereas at 25°C it decreases to $32% after 60 min, with no further change until 120 min. Similar 51 V NMR experiments were carried out in the presence of DIDS, showing that the presence of this anion channel blocker has no significant effect on the time dependent decay of the 51 V NMR signals of both the 1:1 and 1:2 complexes (Fig. 4B(b) ).
The absence of any effect of DIDS on the cell uptake of both complexes shows that none of the two negatively 2 were obtained at different time intervals (data not shown). At t = 0 min the high frequency spectral region showed two signals at 6.2 and 6.5 ppm that are assigned to the H5 proton, and two other signals at 7.4 and 7.6 ppm assigned to the H6 proton of the ligand in the 1:1 and 1:2 species, respectively. After 180 min, these signals significantly decreased in intensity and two doublets at 6.4 and 7.5 ppm appeared, corresponding to the H5 and H6 proton signals of the free Hdmpp at the same pH value [53] . The presence of free ligand in the extracellular medium thus confirms that the 1:2 species decomposes with time, probably into [V V O 2 (dmpp)(H 2 O) 2 ] and free Hdmpp or even vanadate and free ligand ( 51 V NMR spectra of Fig. 4A shows a small signal of free vanadate). The values of the stepwise formation constants reported for the 1:1 and 1:2 species are log K 1 = 10.48 and log K 2 = 5.25 [53] , respectively, supporting the hypothesis that the 1:2 species is preferentially decomposed.
Thus, the present experiments provide evidence that only the neutral 1:1 V V species is taken up by the erythrocytes through passive diffusion, and its depletion from the extracellular medium promotes the dissociation of the 1:2 species.
EPR studies
The presence of these V IV O-signals in erythrocyte lysates confirms the uptake of the vanadium compounds by the cells. Fig. 5 shows EPR spectra of erythrocyte lysates obtained from cell suspensions previously incubated for different time intervals: with vanadate at 25°C (Fig. 5A) , and oxidation products of V IV O(Rpyr 2 en) 2 at 37°C (Fig. 5B ) and V IV O(dmpp) 2 at 37°C (Fig. 5C) , while Fig. 5D shows the time dependence of the EPR signal intensity for the incubations carried out at 25 and 37°C. EPR spectra recorded are relatively weak, especially at low incubation times. This, together with some line broadening, made the high field m I = 7/2 i line barely discernible in most cases. These features (line broadening and low intensity spectra) are common in in vivo EPR studies [49] . Nevertheless, the ±5/2 i and the ±3/2 i lines can be seen, even at low incubation times, and the same is true for the ? part of the spectra, making it possible to accurately simulate the most intense spectrum of each set, thus obtaining the relevant EPR parameters.
EPR spectra of erythrocyte lysates incubated with vanadate show an initial increase in intensity with the incubation time up to 120 min, remaining constant from then on (see Fig. 5A and D) . For cells incubated with DIDS during 10 min prior to the addition of vanadate no EPR signal was detected from the erythrocyte lysates (data not shown). This indicates that vanadium enters the cells as V V through the anionic channel which is blocked by DIDS, in agreement with previous studies [36, 66, 67] .
The erythrocyte suspensions incubated with V IV O(Rpyr 2 en) oxidation products at 37°C give lysates with EPR spectra (see Fig. 5B Overlaying the EPR spectra of erythrocyte lysates incubated with V IV O(Rpyr 2 en) oxidation products with those of aqueous solutions of the original complex at the relevant pH values [50] we conclude that the V IV O-species detected inside the cells is not likely to be the initial intact complex, although both hyperfine coupling constants (A i and A^) obtained from the spectrum of cell lysates are close to those of cis-V IV O(HRpyr 2 en) (see Table 1 ). EPR spectra of erythrocyte lysates obtained from cell suspensions incubated with V IV O(dmpp) 2 oxidation products at 37°C (see Fig. 5C and D) show initially a fast increasing signal intensity up to 60 min incubation time, followed by a constant value. Taking into account the NMR data, we conclude that these EPR spectra result from the passive diffusion of the neutral [V V O 2 (dmpp)(H 2 O) 2 ] complex into the cells, and its subsequent reduction. Concerning the identity of this V IV O-species, the calculated EPR parameters (see Table 1 not maintain its identity inside the cells. The uptake of the V IV O(dmpp) 2 oxidation products was also found to be temperature dependent, the initial EPR signal intensity at 60 min being, ca. 2.5 lower at 25°C than at 37°C (Fig. 5D) .
As indicated by the intensity of the EPR signals (Fig. 5D) , of the two vanadium compounds tested at 37°C, the oxidized V IV O(dmpp) 2 is the one more easily taken up by the erythrocytes, and to a higher extent. After an incubation time of 60 min, the corresponding EPR signal is $1.5 times more intense than that of the oxidized V IV O(Rpyr 2 en) after a 480 min incubation period. The entry of V IV O(dmpp) 2 oxidation products is also faster than that of the vanadate salt, the corresponding EPR spectrum being more intense by a factor of $2.2 at 25°C (for a 60 min incubation period) (Fig. 5D) .
For all vanadium compounds tested the intensity of the EPR signal increases with the incubation time but there are no changes in its features with time. This indicates an increase in the concentration of the same V IV O species in the cells for each set of compounds studied. The EPR spectra of cell lysates incubated with aqueous solutions of vanadate, V IV O(dmpp) 2 and V IV O(Rpyr 2 en) are similar but differ from those of the original complex. This suggests that all V IV O-complexes are decomposed (partially or totally), and that the metal binds to a similar set of donor atoms of intracellular ligands. EPR of V IV O-compounds is very sensitive to the type of ''equatorial'' donors, charge of complex and type of bonds formed. The small differences detected might indicate a similar set of donor atoms placed into a slightly different environment (see Fig. 6 ). The EPR signals obtained from erythrocyte lysates incubated with vanadate are also broader than those incubated with both V IV O complexes. This inhomogeneous line broadening is possibly due to the presence of more than one V IV O species with EPR parameters too close to be distinguished [47] .
The additivity rule for A i and g i can be used to predict the V IV O equatorial coordination environment of the V IV O-species detected. In the present case, this may be e The two species detected are assigned to isomers with equatorially (cis) or axially (trans) coordinated water [50] . f Taken from [68] . g $1 mM in water:ethyleneglycol solution (9:1). h The three species present were assigned to the 1:1 complex, and to the two 1:2 isomers (with the water molecule coordinated either equatorially or axially). more clearly assessed through a representation of the EPR parameters in g i -A i diagrams [45, 56, 59] . Fig. 6 compares a display of data from our study with erythrocytes (dark triangles, points 9, 10 and 11) with related in vivo and in vitro literature data. Our parameters fit well to both a VO(N 2 O 2 ) or a VO(NO 3 ) donor atom set, where N may be e.g. an amine, imine or imidazole (or other), and O could correspond to, e.g. phosphate, carboxylate, or O phenolate (or other). The estimated A i and g i values are too low for a VO(O 4 ) binding mode, which are therefore less likely. Nevertheless, the intensity of the EPR signal is always low, and given the range of different values that O donors may assume, the VO(O 4 ) coordination environment cannot be completely excluded. However, for a VO exclusively to ATP, GSH or GSSG (points 1, 6 and 7, respectively, in Fig. 6 ) can however be excluded in the erythrocyte case. We should briefly mention other possible vanadium species that can be present in the cells besides the EPR-active V IV O-species. Erythrocyte lysates could also contain dimeric or oligomeric V IV species [2, 55, 71] which would be EPR-silent. It is very unlikely that these diamagnetic V IV species would be important in a rich ligand environment such as a cell, which contains a variety of proteins, peptides and other biological compounds that are effective vanadium binders. Some vanadium could also be present as V III or V V . V V -species which are believed to be easily reduced in the thiol-rich erythrocyte intracellular environment, as shown by EPR studies [7] .
Oxidative stress induced by oxovanadium compounds
Oxidative stress induced by vanadate and the oxidation products of the oxovanadium(IV) compounds in erythrocytes was characterized by measuring their effect on the pentose phosphate pathway (PP) flux of erythrocyte suspensions [62] . In these cells, the oxidative branch of the PP generates NADPH, which is almost entirely used in the regeneration of reduced glutathione by NADP-glutathione reductase. Oxidative stress will accelerate glutathione cycling (GSH M GSSG), which results in increased NADPH consumption and stimulation of PP flux [72] . PP fluxes were estimated from the ratio of excess 13 Cenrichment in lactate carbon 3 relative to carbon 2, according to established metabolic models [62] . As shown in Fig. 7A and inset (a), the 1 H NMR spectrum of the methyl group of lactate has well-resolved signals from 13 C-isotopomers formed as a result of [2- 13 C]glucose metabolism through the glycolytic and PP pathways, which correspond to 13 C enrichment of lactate in carbon 2 (Q2 signal) and in carbon 3 (Q3 signal), respectively [62] . In quiescent erythrocytes, the control group, 13 C enrichment of lactate carbon 3 relative to carbon 2 (C3/C2) was low (6.8 ± 2.5%), consistent with baseline PP activity of erythrocytes. In the presence of methylene blue, a classical activator of erythrocyte glutathione oxidation, lactate C3/C2 ratio was substantially higher (26.0 ± 12.9%), reflecting a significant (p < 0.01) activation of PP flux and generation of NADPH for the glutathione redox cycle [62] . 1 H NMR spectra with similar features were obtained when vanadate and the oxovanadium compounds were tested in 1 and 5 mM concentration. Fig. 7B shows the results obtained from 1 H NMR data. The value of pentose cycle activation obtained for the group stimulated with 1 mM vanadate is 6.3 ± 1.5%, which does not differ significantly (p > 0.05) from the control, but is significantly different (p < 0.05) from the group treated with methylene blue. The same happens when stimulation with 1 mM V IV O(Rpyr 2 en) or 1 mM V IV O(dmpp) 2 oxidation products occurs, where the pentose cycle activation is 9.8 ± 4.7% and 4.7 ± 1.5% (p < 0.05 relative to the group treated with methylene blue), respectively. These results indicate that vanadate and the oxovanadium compounds tested do not significantly activate the pentose cycle in the 1 mM concentration used, showing that the oxidative stress induced by these vanadium compounds in the present conditions is negligible, as far as erythrocytes are concerned.
At 5 mM all the vanadium compounds tested show increased induced oxidative stress. The value of pentose cycle activation obtained for the group stimulated with 5 mM vanadate is 17.5 ± 3.5%, which differs significantly from the control (p < 0. Previous toxicity tests carried out with a large number of vanadium compounds on transformed fibroblasts from mice (cell line SV 3T3) showed that toxic effects increase with increasing exposure time of the cells to the vanadium compounds, and that most of the vanadium compounds studied, including V IV O(dmpp) 2 and vanadate, are toxic at 1 mM concentration, but not V IV O(Rpyr 2 en), which is in agreement with our results [18] . Although vanadium toxicity depends on many factors besides oxidative stress, and its assessment depends on the method used, we emphasize that these toxicity results reported in the literature correlate well with the oxidative stress data obtained in this work, as assessed by the activation of the PP flux in erythrocytes exposed to 5 mM vanadium compounds.
Glucose intake in the presence of oxovanadium compounds
The glucose present in the extracellular medium of erythrocyte suspensions after incubation with 1 mM vanadate or oxovanadium compounds at 37°C during 8 h was determined using a biochemical assay. The hexokinase method provides a high degree of specificity for estimating glucose [73] , whereby glucose is measured by quantifying the reduced NADPH formed from the net reactions catalyzed by hexokinase and glucose-6-phosphate dehydrogenase [63] . Fig. 8 shows that at 37°C and 1 mM concentration only oxidized V IV O(dmpp) 2 significantly increased the glucose intake rate (0.75 ± 0.13 mM/h, p < 0.05) by erythrocytes relative to the control (0.37 ± 0.17 mM/h). At room temperature and in the whole blood without addition of a glycolysis inhibitor, glucose is metabolized at a rate higher than that observed for the control group (approximately 0.4 mM/h [74] ), especially if it is taken into account that this rate value was obtained at 37°C. However, in this study erythrocyte suspensions were used instead of the whole blood, and the experiments were carried out during several hours without perfusion. This might have affected cellular metabolism and consequently the glucose intake rate. Glucose intake rates for the groups stimulated with vanadate (0.46 ± 0.05 mM/h) and oxidized V IV O(Rpyr 2 en) (0.51 ± 0.11 mM/h) do not significantly (p > 0.05) increase relative to the control. The group stimulated with methylene blue, used as a negative control in the oxidative stress experiments, also showed a significant (p < 0.05) increase in the glucose intake rate (0.90 ± 0.12 mM/h) relative to the control, which is closely related to the observed increase in PP flux (see Fig. 7B ). The fact that only stimulation with oxidized V IV O(dmpp) 2 had an effect on glucose intake rate may be strongly related with the larger amount of vanadium taken up by the cells in this case, as a result of the facilitated influx of this compound by passive diffusion.
It is known from in vivo studies that the serum levels of glucose and free fatty acids (FFA) correlate well in normal and STZ rats, and that the FFA serum level is a good index of the degree of Diabetes Mellitus [75, 11] . Previous studies with V IV O(dmpp) 2 showed a dose-dependent inhibitory effect on the FFA release from epinephrine-stimulated rat adipocytes in the presence of glucose. V IV O(dmpp) 2 is effective at concentrations that are 5.7 times lower than that observed for vanadyl sulfate. Moreover, IC 50 values for V IV O(dmpp) 2 are approximately half of that observed for vanadyl sulfate [54] . Another study reported that in Human and SV 3T3 fibroblasts, 1 mM V IV O(dmpp) 2 affects glucose intake in a similar level of that observed in the same conditions for the same concentration of insulin, whereas on SV 3T3 fibroblasts V IV O(Rpyr 2 en) is more effective than insulin in concentrations of the compound lower than 1 mM [18] . The insulin mimetism observed in the mentioned studies, for the vanadium compound V IV O(dmpp) 2 , with coordination mode VO(O 4 ), is in agreement with another study where similar properties were observed for the vanadium compounds with the same coordination mode [26, 27] .
Concluding remarks
The interaction of the oxidation products of two oxovanadium(IV) compounds, V IV O(Rpyr 2 en) and V IV O(dmpp) 2 , with human erythrocytes was studied to mimic some of the biological events that might occur in blood, following the oral administration of the complexes. The decrease with time of the intensity of 51 V NMR signals of V V species present in the extracellular medium of erythrocyte suspensions indicates their uptake by the cells. On the other hand, the increasing intensity of the V IV O EPR signal observed with time in the erythrocyte lysates indicates the presence of V IV paramagnetic species inside the cells. This means that the cells are taking up the vanadium which is then reduced inside the cells to new V IV O-species, most likely with a VO(NO 3 ) or VO(N 2 O 2 ) binding mode. However, the small differences observed in the EPR signals indicate that the species detected is not the same in each set of spectra corresponding to each vanadium compound. The data indicate that the ligand is partially or totally replaced, but total replacement by ATP, GSH or GSSG is excluded.
The uptake results indicate that the neutral V V O 2 (HRpyr 2 en) species slowly enters the cells by passive diffusion. This compound does not promote oxidative stress in erythrocytes at 1 mM concentration and its effect on glucose intake by erythrocytes is negligible. In aqueous aerobic solution V IV O(dmpp) 2 is fully oxidized after 12 h to two V V complexes with different stoichiometries. The neutral 1:1 species [V V O 2 (dmpp)(H 2 O) 2 ] rapidly enters the erythrocytes by passive diffusion, with an influx rate faster than for V V O 2 (HRpyr 2 en). Once inside the cells, it is reduced to V IV O-species. An increase in glucose intake relative to the control was observed when the cells were incubated with 1 mM of this compound. This occurs without a concomitant increase of the PP flux. Thus, oxidized V IV O(dmpp) 2 activates glycolysis by a factor of about two relative to the control, without induced oxidative stress.
The methodology described in this work, when extended to insulin target cells, such as adipocytes or hepatocytes, can be an informative tool to study some relevant properties of the potential insulin mimetic vanadium compounds synthesized worldwide, and thus play an important role in the selection of compounds for further in vitro and in vivo studies.
